Significance of IL-6 in the transition of hormone-resistant prostate cancer and the induction of myeloid-derived suppressor cells (Q39337946)

11 September 2017

Significance of IL-6 in the transition of hormone-resistant prostate cancer and the induction of myeloid-derived suppressor cells (English)

1 reference

11 September 2017

1 reference

Chun-Te Wu

1

1 reference

11 September 2017

Ching-Chuan Hsieh

2

1 reference

11 September 2017

Cheng-Chia Lin

3

1 reference

11 September 2017

Wen-Cheng Chen

4

1 reference

11 September 2017

Ji-Hong Hong

5

1 reference

11 September 2017

Miao-Fen Chen

6

1 reference

11 September 2017

language of work or name

1 reference

3 June 2012

1 reference

Journal of Molecular Medicine

11 September 2017

1 reference

11 September 2017

90

1 reference

11 September 2017

11

1 reference

11 September 2017

1343-1355

1 reference

https://scigraph.springernature.com/pub.10.1007/s00109-012-0916-x

11 September 2017

0 references

cites work

Molecular determinants of resistance to antiandrogen therapy

1 reference

https://api.crossref.org/works/10.1007%2FS00109-012-0916-X

The androgen receptor and signal-transduction pathways in hormone-refractory prostate cancer. Part 1: Modifications to the androgen receptor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-012-0916-X

Role of DNA methyltransferase 1 in hormone-resistant prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-012-0916-X

Interleukin-6: from basic science to medicine--40 years in immunology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-012-0916-X

IL-6 involvement in epithelial cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-012-0916-X

Interleukin-6 regulation of prostate cancer cell growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-012-0916-X

Significance of interleukin-6 signaling in the resistance of pharyngeal cancer to irradiation and the epidermal growth factor receptor inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-012-0916-X

21 January 2018

Inflammation and cancer

1 reference

https://api.crossref.org/works/10.1007%2FS00109-012-0916-X

Inflammation and cancer: back to Virchow?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-012-0916-X

Inflammation induces myeloid-derived suppressor cells that facilitate tumor progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-012-0916-X

Gemcitabine selectively eliminates splenic Gr-1+/CD11b+ myeloid suppressor cells in tumor-bearing animals and enhances antitumor immune activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-012-0916-X

Myeloid-derived suppressor cells as regulators of the immune system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-012-0916-X

Antigen-specific inhibition of CD8+ T cell response by immature myeloid cells in cancer is mediated by reactive oxygen species.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-012-0916-X

Interleukin-6 stimulation of growth of prostate cancer in vitro and in vivo through activation of the androgen receptor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-012-0916-X

Recruitment of myeloid but not endothelial precursor cells facilitates tumor regrowth after local irradiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-012-0916-X

Stats: transcriptional control and biological impact

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-012-0916-X

The IL-6/sIL-6R complex as a novel target for therapeutic approaches

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-012-0916-X

Inhibition of interleukin-6 with CNTO328, an anti-interleukin-6 monoclonal antibody, inhibits conversion of androgen-dependent prostate cancer to an androgen-independent phenotype in orchiectomized mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-012-0916-X

The anti-interleukin-6 antibody siltuximab down-regulates genes implicated in tumorigenesis in prostate cancer patients from a phase I study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-012-0916-X

Epithelial-mesenchymal transitions in tumour progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-012-0916-X

Randomised phase II study of siltuximab (CNTO 328), an anti-IL-6 monoclonal antibody, in combination with mitoxantrone/prednisone versus mitoxantrone/prednisone alone in metastatic castration-resistant prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-012-0916-X

Association of pre- and postoperative plasma levels of transforming growth factor beta(1) and interleukin 6 and its soluble receptor with prostate cancer progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-012-0916-X

The prognostic significance of plasma interleukin-6 levels in patients with metastatic hormone-refractory prostate cancer: results from cancer and leukemia group B 9480.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-012-0916-X

Targeting immune suppressing myeloid-derived suppressor cells in oncology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-012-0916-X

Immature myeloid cells and cancer-associated immune suppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-012-0916-X

Inhibition of Mac-1 (CD11b/CD18) enhances tumor response to radiation by reducing myeloid cell recruitment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-012-0916-X

Morphology of angiogenesis in human cancer: a conceptual overview, histoprognostic perspective and significance of neoangiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-012-0916-X

Expansion of myeloid immune suppressor Gr+CD11b+ cells in tumor-bearing host directly promotes tumor angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-012-0916-X

The radiation response of hormone-resistant prostate cancer induced by long-term hormone therapy

21 January 2018

1 reference

12 December 2020

Evidence for clonal outgrowth of androgen-independent prostate cancer cells from androgen-dependent tumors through a two-step process

1 reference

12 December 2020

Radiation can inhibit tumor growth indirectly while depleting circulating leukocytes

1 reference

12 December 2020

Interleukin-6: a multifunctional targetable cytokine in human prostate cancer

1 reference

12 December 2020

Targeting AKT/mTOR and ERK MAPK signaling inhibits hormone-refractory prostate cancer in a preclinical mouse model

1 reference

12 December 2020

Inhibition of the differentiation of dendritic cells from CD34(+) progenitors by tumor cells: role of interleukin-6 and macrophage colony-stimulating factor.

1 reference

12 December 2020

10.1007/S00109-012-0916-X

Identifiers

DOI

1 reference

11 September 2017

1 reference